PTC Therapeutics Inc (NAS:PTCT)
$ 36.53 3.23 (9.7%) Market Cap: 2.80 Bil Enterprise Value: 2.34 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

PTC Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 12:20AM GMT
Release Date Price: $30.98 (-6.80%)
Daniele Drago

All right. Good afternoon, everyone. Thank you for joining us today for our last session of the day. My name is Daniele Drago. I'm one of Tazeen Ahmad's associates here at Bank of America, and I have with me today, Matthew Klein, Chief Operating Officer; and Kylie O'Keefe, SVP of Commercial -- Global Commercial and corporate strategy from PTC Therapeutics. So welcome, guys. And maybe we can start by -- you guys can introduce yourself and maybe you can give us a brief overview of the company and key catalysts for the year.

Matthew B. Klein
PTC Therapeutics, Inc. - COO

Sure. So thank you very much, Daniele. For those of you who might not be familiar with PTC Therapeutics, we're a global biopharmaceutical company with multiple platforms each built on pioneering science. We are focused on discovering, developing and commercializing innovative therapies for rare disorders while delivering significant value to all of our stakeholders. We've built a robust pipeline of therapies that moves us towards our goal of delivering new therapeutics in a steady stream

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot